KBC Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Sell |
4,195
-1,905
| -31% | -$82.2K | ﹤0.01% | 905 |
|
|
2025
Q1 | $211K | Buy |
6,100
+153
| +3% | +$5.29K | ﹤0.01% | 1038 |
|
|
2024
Q4 | $163K | Buy |
5,947
+2,456
| +70% | +$67.3K | ﹤0.01% | 1247 |
|
|
2024
Q3 | $89K | Buy |
3,491
+649
| +23% | +$16.5K | ﹤0.01% | 1359 |
|
|
2024
Q2 | $72K | Hold |
2,842
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q1 | $88K | Buy |
2,842
+887
| +45% | +$27.5K | ﹤0.01% | 1190 |
|
|
2023
Q4 | $79K | Sell |
1,955
-256
| -12% | -$10.3K | ﹤0.01% | 1209 |
|
|
2023
Q3 | $58K | Buy |
+2,211
| New | +$58K | ﹤0.01% | 1322 |
|